Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04893291Not ApplicableActive Not Recruiting

Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II

Role: lead

NCT07390994Not Yet Recruiting

The PICCOLETO IX PHENO Study

Role: lead

NCT07391033Not Yet Recruiting

The PICCOLETO XI A-PREP Study

Role: lead

NCT06535568Not ApplicableRecruiting

Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

Role: lead

NCT06551662Not ApplicableRecruiting

DCB vs. DES in Bifurcation Coronary Lesions

Role: lead

All 5 trials loaded